{"cdcTestId":"2021-0014","testcaseName":"Dose #1 of the Novavax Covid-19 Vaccine ","vaccineGroup":"COVID-19","evaluationTestType":"Vaccine: Invalid Usage","forecastTestType":"Recommended based on interval","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"1982-10-19T00:00:00","gender":"M"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Novavax COVID-19 Vaccine","cvx":"211","mvx":"NVX","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2022-11-09T00:00:00","recommendedDate":"2022-11-09T00:00:00","pastDueDate":"2022-12-13T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Novavax COVID-19 Vaccine","cvx":"211","mvx":"NVX","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2020-10-06T20:00:00","dateUpdated":"2022-07-22T12:50:04.397","generalDescription":"This test case describes when a patient is administered the first dose of the two-dose Novavax Covid-19 vaccine, that the dose is considered valid.  Another dose should be forecast.","changedInVersion":"4.25","reasonForChange":"v4.25:: Updated test cast to align with the current Interim Clinical Considerations on 07/20/2022 concerning the use of the Novavax Covid-19 vaccine.\nv4.20: Updated test case to align with Interim Clinical Considerations for \u0022People who received Covid-19 vaccine as part of a clinical trial\u0022 by forecasting a second dose."}